Biomarkers /

NCOA1

Back to Biomarkers List

Overview

Location [1]
2p23.3
Protein [2]
Nuclear receptor coactivator 1
Synonyms [1]
RIP160, KAT13A, bHLHe42, SRC1, bHLHe74, F-SRC-1

NCOA1 is altered in 0.10% of all cancers with high grade ovarian serous adenocarcinoma, lung adenocarcinoma, endometrial endometrioid adenocarcinoma, cervical squamous cell carcinoma, and bladder urothelial carcinoma having the greatest prevalence of alterations [3].

NCOA1 GENIE Cases - Top Diseases

The most common alterations in NCOA1 are NCOA1-ALK Fusion (0.08%), NCOA1 P518R (0.77%), NCOA1 T377N (0.77%), NCOA1 A715T (0.22%), and NCOA1 C784W (0.85%) [3].

NCOA1 GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.